The drugmaker’s U.S. expansion comes on the heels of a rough quarter, with lower vaccine demand driving down Q3 sales by 15% ...

GSK is enlisting the aid of China’s Chongqing Zhifei Biological Products (Zhifei) to drive sales of its most important vaccine, Shingrix, in China over the next few years, and may also call upon ...

On the downside, GSK's COVID-19 therapy Xevudy (sotrovimab) saw a slump in demand, with sales falling to £500 million from £1.3 billion in the first quarter of 2022, and GSK is expecting the ...

Sherman Yu, GSK Vice President and GSK China General Manager ... In the vaccines area, highlights include Shingrix, which is a recombinant shingles vaccine that combines antigens and adjuvant systems ...

Dubai, United Arab Emirates – Dubai Health Authority (DHA) and GSK, a global science-led UK healthcare company, have signed a General Collaboration Agreement (GCA) tackling adult immunization ...

Teva Pharmaceutical Industries Ltd. ADR-2.23% $19.91B ...

As of November 08, 2024, GSK plc had a $73.1 billion market capitalization, putting it in the 96th percentile of companies in the Pharmaceuticals industry. Currently, GSK plc’s price-earnings ratio is ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Company has Deloitte Haskins & Sells LLP as its auditors. As on 30-06-2024, the company has a total of 16.94 Crore shares outstanding.GSK Pharma Share Price Today is Rs. 2561.15 as on 08 Nov, 2024, 03 ...

Even single day's delay in deciding bail plea adversely affects fundamental rights of citizens: SC NEW DELHI: Deprecating the practice of courts keeping bail applications pending for years, the ...